Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01572116Phase 2Completed
Phase 2, randomised, double-blind trial in irreversible pulpitis comparing Placebo Control with Sufentanil Group (2 arms). Primary endpoint: Depth of anesthesia. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01572116.